SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses of $15.09M in Q1 FY2026

Q1 FY2026 operating expenses was $15.09M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$15.09M+12.5% QoQ
Last fiscal yearDec 2025
$40.84M— YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
40.84M USD
Year-over-year change
—

Operating Expenses vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Operating Expenses for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$5.15B USD+23.4%+2.5%47.1%
BLCOBausch + Lomb CorporationLTM Jun 2026$2.66B USD-1.5%+8.5%50.1%
GKOSGlaukos CorporationLTM Jun 2026$565.37M USD+32.3%+17.5%92.3%
OCULOcular Therapeutix, Inc.LTM Mar 2026$344.84M USD+33.6%+35.9%662.7%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$287.65M USD+34.6%+27.1%3777.4%
STAASTAAR Surgical CompanyLTM Apr 2026$226.94M USD-17.3%+8.3%78.2%
RXSTRxSight, Inc.LTM Mar 2026$153.52M USD+7.0%+21.3%120.4%
SGHTSight Sciences, Inc.LTM Mar 2026$104.2M USD-10.6%-10.1%131.0%
OCSOculis Holding AGLTM Mar 2026CHF 69.81M CHF-10.3%+34.7%13851.6%
SGPSpyGlass Pharma, Inc. Common StockFY2025$40.84M USD———
Peer median (excluding SGP) —+7.0%+17.5%120.4%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.